Table 1 Descriptive statistics study cohort and their association with treatment effect.

From: Multi-omic analyses of triptan-treated migraine attacks gives insight into molecular mechanisms

 

Mean (SD)

N (yes/no)

P value*

Age

37.6 (10.9)

 

0.95

BMI

23.2 (3.0)

 

0.87

Migraine attacks/month

4.3 (4.2)

 

0.43

Heart rate

68.4 (8.0)

 

0.88

Blood pressure

 Systolic

123 (11)

 

0.86

 Diastolic

77 (9)

 

0.44

Medication use

 Prophylactic migraine

 

3/24

0.62

 Acute migraine

 

22/2

0.94

 Concomitant

 

12/12

0.52

Medical history

 Psychiatric

 

8/16

0.45

 CNS

 

5/18

0.93

 Cardiopulmonary

 

4/20

0.84

 Endocrine

 

1/23

NA

 Gastrointestinal

 

3/21

0.79

 Urogenital

 

5/19

0.91

 Gynecological

 

6/18

0.67

 Musculoskeletal

 

8/15

0.70

Provoking factors

 Physical activity

 

10/14

0.42

 Light

 

13/11

0.58

 Stress

 

21/3

0.61

 Menstruation

 

15/8

0.37

 Alcohol

 

12/11

0.69

 Fragrances

 

9/15

0.40

 Sleep deprivation

 

19/4

0.11

 Sleep excess

 

19/4

0.11

  1. *Association with reduction in headache score (VAS) using a t-test (binomial features) or linear regression (continuous features).
Back to article page